NRD
GMED icon

Nebula Research & Development’s Globus Medical GMED Stock Holding History

Nebula Research & Development’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,113
Closed -$543K – 559
2023
Q2 		$543K Buy
+9,113
New +$519K 0.41% 118

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nebula Research & Development's GMED Position: Q3 2023 in Review

Nebula Research & Development sold out of Globus Medical (GMED) in Q3 2023, closing a stake of 9,113 shares — an estimated $543K sold.

Nebula Research & Development first reported a position in GMED in Q2 2023 and held it in 1 quarter. The position peaked at $543K in Q2 2023. 431 funds tracked by Wall St. Rank hold GMED as of Q3 2023.

  • Nebula Research & Development reported no remaining Globus Medical position as of Q3 2023 after selling out during the quarter.
  • Nebula Research & Development sold 9,113 Globus Medical shares in Q3 2023, an estimated $543K.
  • Nebula Research & Development first reported a position in Globus Medical in Q2 2023 and held it in 1 quarter.
  • Nebula Research & Development's Globus Medical position peaked at $543K in Q2 2023.
  • 431 funds tracked by Wall St. Rank held Globus Medical as of Q3 2023.

Based on Nebula Research & Development's 13F filing for Q3 2023, filed 14 Nov 2023.